Assertio (ASRT) Stock Forecast, Price Target & Predictions
ASRT Stock Forecast
Assertio stock forecast is as follows: an average price target of $2.88 (represents a 171.70% upside from ASRT’s last price of $1.06) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ASRT Price Target
ASRT Analyst Ratings
Assertio Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 26, 2024 | Naz Rahman | Maxim Group | $3.00 | $1.47 | 104.08% | 183.02% |
May 28, 2024 | Scott Henry | Industrial Alliance Securities | $2.75 | $1.00 | 175.00% | 159.43% |
Assertio Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $2.88 |
Last Closing Price | $1.06 | $1.06 | $1.06 |
Upside/Downside | -100.00% | -100.00% | 171.70% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 03, 2024 | H.C. Wainwright | - | Buy | Initialise |
May 28, 2024 | Alliance Global Partners | - | Buy | Initialise |
Assertio Financial Forecast
Assertio Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $35.63M | $40.99M | $42.47M | $50.35M | $34.21M | $35.13M | $36.54M | $33.33M | $25.47M | $25.37M | $26.84M | $30.18M | $34.56M | $20.62M | $20.92M | $59.23M | $55.15M |
Avg Forecast | $29.00M | $29.20M | $29.41M | $29.62M | $34.12M | $32.88M | $31.80M | $30.99M | $29.30M | $28.87M | $30.08M | $29.30M | $33.60M | $50.17M | $39.83M | $37.64M | $47.33M | $31.36M | $31.78M | $32.66M | $30.38M | $21.64M | $19.98M | $23.98M | $27.30M | $32.35M | $25.17M | $10.95M | $25.01M | $50.57M |
High Forecast | $29.00M | $29.20M | $29.41M | $29.62M | $34.12M | $32.88M | $31.80M | $30.99M | $29.30M | $29.22M | $30.08M | $29.30M | $33.60M | $50.30M | $39.83M | $37.64M | $47.33M | $31.36M | $31.78M | $32.66M | $30.38M | $21.64M | $19.98M | $23.98M | $27.30M | $32.35M | $25.17M | $10.95M | $25.01M | $50.57M |
Low Forecast | $29.00M | $29.20M | $29.41M | $29.62M | $34.12M | $32.88M | $31.80M | $30.99M | $29.30M | $28.51M | $30.08M | $29.30M | $33.60M | $50.05M | $39.83M | $37.64M | $47.33M | $31.36M | $31.78M | $32.66M | $30.38M | $21.64M | $19.98M | $23.98M | $27.30M | $32.35M | $25.17M | $10.95M | $25.01M | $50.57M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.71% | 1.03% | 1.13% | 1.06% | 1.09% | 1.11% | 1.12% | 1.10% | 1.18% | 1.27% | 1.12% | 1.11% | 1.07% | 0.82% | 1.91% | 2.37% | 1.09% |
Assertio EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-228.27M | $19.80M | $21.10M | $29.90M | $18.38M | $19.96M | $22.45M | $14.86M | $13.69M | $-4.39M | $14.59M | $-25.85M | $-273.00K | $-37.12M | $60.02M | $-158.70M | $41.21M |
Avg Forecast | $8.76M | $8.83M | $8.89M | $8.95M | $10.31M | $9.94M | $9.61M | $9.37M | $8.85M | $8.72M | $9.09M | $26.23M | $10.15M | $15.16M | $12.04M | $20.73M | $5.32M | $9.48M | $9.60M | $16.39M | $9.18M | $6.54M | $6.04M | $16.05M | $8.25M | $9.78M | $7.61M | $3.31M | $7.56M | $15.28M |
High Forecast | $8.76M | $8.83M | $8.89M | $8.95M | $10.31M | $9.94M | $9.61M | $9.37M | $8.85M | $8.83M | $9.09M | $31.47M | $10.15M | $15.20M | $12.04M | $24.88M | $6.39M | $9.48M | $9.60M | $19.67M | $9.18M | $6.54M | $6.04M | $19.26M | $8.25M | $9.78M | $7.61M | $3.31M | $7.56M | $15.28M |
Low Forecast | $8.76M | $8.83M | $8.89M | $8.95M | $10.31M | $9.94M | $9.61M | $9.37M | $8.85M | $8.62M | $9.09M | $20.98M | $10.15M | $15.12M | $12.04M | $16.59M | $4.26M | $9.48M | $9.60M | $13.11M | $9.18M | $6.54M | $6.04M | $12.84M | $8.25M | $9.78M | $7.61M | $3.31M | $7.56M | $15.28M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -15.06% | 1.64% | 1.02% | 5.62% | 1.94% | 2.08% | 1.37% | 1.62% | 2.09% | -0.73% | 0.91% | -3.13% | -0.03% | -4.88% | 18.14% | -21.00% | 2.70% |
Assertio Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-279.54M | $8.47M | $-3.48M | $88.55M | $4.17M | $7.83M | $9.06M | $4.61M | $3.74M | $-14.17M | $4.54M | $-24.35M | $-10.52M | $-34.50M | $41.23M | $-192.63M | $3.33M |
Avg Forecast | $6.67M | $4.76M | $3.81M | $3.81M | $952.40K | $952.40K | $-1.59M | $-2.22M | $-4.38M | $-4.19M | $-3.05M | $11.43M | $-1.90M | $9.05M | $17.68M | $9.03M | $-17.02M | $6.70M | $9.52M | $7.14M | $7.62M | $11.43M | $11.43M | $5.00M | $-13.33M | $-11.43M | $-32.38M | $120.60M | $53.33M | $92.70M |
High Forecast | $6.67M | $4.76M | $3.81M | $3.81M | $952.40K | $952.40K | $-1.59M | $-2.22M | $-4.38M | $-3.14M | $-3.05M | $13.71M | $-1.90M | $9.05M | $17.68M | $10.84M | $-13.62M | $6.70M | $9.52M | $8.57M | $7.62M | $11.43M | $11.43M | $6.00M | $-13.33M | $-11.43M | $-32.38M | $144.72M | $53.33M | $92.70M |
Low Forecast | $6.67M | $4.76M | $3.81M | $3.81M | $952.40K | $952.40K | $-1.59M | $-2.22M | $-4.38M | $-5.24M | $-3.05M | $9.14M | $-1.90M | $9.05M | $17.68M | $7.23M | $-20.43M | $6.70M | $9.52M | $5.71M | $7.62M | $11.43M | $11.43M | $4.00M | $-13.33M | $-11.43M | $-32.38M | $96.48M | $53.33M | $92.70M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -30.90% | 0.48% | -0.39% | -5.20% | 0.62% | 0.82% | 1.27% | 0.60% | 0.33% | -1.24% | 0.91% | 1.83% | 0.92% | 1.07% | 0.34% | -3.61% | 0.04% |
Assertio SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $21.00M | $16.77M | $16.90M | $13.71M | $11.90M | $10.54M | $10.64M | $13.28M | $9.31M | $26.23M | $7.73M | $23.13M | $25.75M | $28.13M | $27.31M | $22.95M | $36.12M |
Avg Forecast | $15.77M | $15.88M | $15.99M | $16.11M | $18.55M | $17.88M | $17.29M | $16.85M | $15.93M | $15.70M | $16.36M | $13.41M | $18.27M | $27.28M | $21.66M | $10.60M | $24.85M | $17.05M | $17.28M | $8.38M | $16.52M | $11.77M | $10.87M | $8.50M | $14.84M | $17.59M | $13.69M | $5.95M | $13.60M | $27.50M |
High Forecast | $15.77M | $15.88M | $15.99M | $16.11M | $18.55M | $17.88M | $17.29M | $16.85M | $15.93M | $15.89M | $16.36M | $16.09M | $18.27M | $27.35M | $21.66M | $12.72M | $29.82M | $17.05M | $17.28M | $10.06M | $16.52M | $11.77M | $10.87M | $10.20M | $14.84M | $17.59M | $13.69M | $5.95M | $13.60M | $27.50M |
Low Forecast | $15.77M | $15.88M | $15.99M | $16.11M | $18.55M | $17.88M | $17.29M | $16.85M | $15.93M | $15.51M | $16.36M | $10.73M | $18.27M | $27.21M | $21.66M | $8.48M | $19.88M | $17.05M | $17.28M | $6.71M | $16.52M | $11.77M | $10.87M | $6.80M | $14.84M | $17.59M | $13.69M | $5.95M | $13.60M | $27.50M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.77% | 1.59% | 0.55% | 0.70% | 0.61% | 1.27% | 0.80% | 0.79% | 2.41% | 0.91% | 1.56% | 1.46% | 2.06% | 4.59% | 1.69% | 1.31% |
Assertio EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-3.42 | $0.15 | $-0.07 | $1.83 | $0.09 | $0.17 | $0.20 | $0.10 | $0.08 | $-0.32 | $0.12 | $-0.80 | $-0.36 | $-1.40 | $2.32 | $-10.60 | $0.20 |
Avg Forecast | $0.07 | $0.05 | $0.04 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.02 | $-0.05 | $-0.04 | $-0.03 | $-0.01 | $-0.02 | $0.10 | $0.19 | $0.18 | $0.57 | $0.07 | $0.10 | $0.08 | $0.08 | $0.12 | $0.12 | $0.08 | $-0.14 | $-0.12 | $-0.34 | $-0.32 | $0.56 | $0.97 |
High Forecast | $0.07 | $0.05 | $0.04 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.02 | $-0.05 | $-0.03 | $-0.03 | $-0.01 | $-0.02 | $0.10 | $0.19 | $0.18 | $0.57 | $0.07 | $0.10 | $0.08 | $0.08 | $0.12 | $0.12 | $0.08 | $-0.14 | $-0.12 | $-0.34 | $-0.32 | $0.56 | $0.97 |
Low Forecast | $0.07 | $0.05 | $0.04 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.02 | $-0.05 | $-0.06 | $-0.03 | $-0.01 | $-0.02 | $0.10 | $0.19 | $0.18 | $0.57 | $0.07 | $0.10 | $0.08 | $0.08 | $0.12 | $0.12 | $0.08 | $-0.14 | $-0.12 | $-0.34 | $-0.32 | $0.56 | $0.97 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -36.00% | 0.81% | -0.38% | 3.20% | 1.28% | 1.70% | 2.50% | 1.25% | 0.67% | -2.67% | 1.50% | 5.71% | 3.00% | 4.12% | -7.25% | -18.93% | 0.21% |
Assertio Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ESPR | Esperion Therapeutics | $2.00 | $16.00 | 700.00% | Buy |
IRWD | Ironwood Pharmaceuticals | $4.19 | $11.67 | 178.52% | Buy |
ASRT | Assertio | $1.06 | $2.88 | 171.70% | Buy |
PCRX | Pacira BioSciences | $16.45 | $40.00 | 143.16% | Hold |
EOLS | Evolus | $16.42 | $24.00 | 46.16% | Buy |
ANIP | ANI Pharmaceuticals | $56.01 | $79.00 | 41.05% | Buy |
AMPH | Amphastar Pharmaceuticals | $50.59 | $66.00 | 30.46% | Buy |
CTLT | Catalent | $58.69 | $76.40 | 30.18% | Hold |
ALKS | Alkermes | $26.59 | $34.38 | 29.30% | Hold |
COLL | Collegium Pharmaceutical | $32.72 | $41.50 | 26.83% | Buy |
ALVO | Alvotech | $12.92 | $16.00 | 23.84% | Hold |
NBIX | Neurocrine Biosciences | $120.53 | $147.70 | 22.54% | Buy |
ITCI | Intra-Cellular Therapies | $86.17 | $94.50 | 9.67% | Buy |
LFCR | Lifecore Biomedical | $5.99 | $6.50 | 8.51% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
AMRX | Amneal Pharmaceuticals | $8.41 | $8.00 | -4.88% | Buy |
AGRX | Agile Therapeutics | $1.51 | $1.00 | -33.77% | Buy |
ASRT Forecast FAQ
Is Assertio a good buy?
Yes, according to 2 Wall Street analysts, Assertio (ASRT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of ASRT's total ratings.
What is ASRT's price target?
Assertio (ASRT) average price target is $2.88 with a range of $2.75 to $3, implying a 171.70% from its last price of $1.06. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Assertio stock go up soon?
According to Wall Street analysts' prediction for ASRT stock, the company can go up by 171.70% (from the last price of $1.06 to the average price target of $2.88), up by 183.02% based on the highest stock price target, and up by 159.43% based on the lowest stock price target.
Can Assertio stock reach $2?
ASRT's average twelve months analyst stock price target of $2.88 supports the claim that Assertio can reach $2 in the near future.
What are Assertio's analysts' financial forecasts?
Assertio's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $129.79M (high $129.79M, low $129.79M), average EBITDA is $39.22M (high $39.22M, low $39.22M), average net income is $-1.905M (high $-1.905M, low $-1.905M), average SG&A $70.58M (high $70.58M, low $70.58M), and average EPS is $-0.02 (high $-0.02, low $-0.02). ASRT's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $117.24M (high $117.24M, low $117.24M), average EBITDA is $35.43M (high $35.43M, low $35.43M), average net income is $19.05M (high $19.05M, low $19.05M), average SG&A $63.75M (high $63.75M, low $63.75M), and average EPS is $0.2 (high $0.2, low $0.2).
Did the ASRT's actual financial results beat the analysts' financial forecasts?
Based on Assertio's last annual report (Dec 2022), the company's revenue was $156.23M, beating the average analysts forecast of $143.13M by 9.16%. Apple's EBITDA was $91.21M, beating the average prediction of $40.79M by 123.58%. The company's net income was $109.62M, beating the average estimation of $6.34M by 1629.07%. Apple's SG&A was $46.79M, missing the average forecast of $67.56M by -30.75%. Lastly, the company's EPS was $2.33, beating the average prediction of $0.822 by 183.34%. In terms of the last quarterly report (Sep 2023), Assertio's revenue was $35.63M, missing the average analysts' forecast of $50.17M by -28.99%. The company's EBITDA was $-228M, missing the average prediction of $15.16M by -1605.57%. Assertio's net income was $-280M, missing the average estimation of $9.05M by -3189.64%. The company's SG&A was $21M, missing the average forecast of $27.28M by -23.01%. Lastly, the company's EPS was $-3.42, missing the average prediction of $0.095 by -3700.00%